Latest Hypertension News
Losartan treatment is linked to aldosterone reductions in patients with hypertension but not obstructive sleep apnea.
Findings indicate high-risk adults would benefit from intensive program to lower SBP to 120 or less.
Add-on mineralocorticoid receptor antagonist therapy increased serum potassium by 0.4 mEq.
Low DBP linked to myocardial damage, CHD events especially among those with SBP 120 mm Hg.
Significantly higher nighttime systolic blood pressure, especially in patients with diabetes and low eGFR.
Black CKD patients with strict blood pressure control had a 19% lower risk of premature death.
Sleep apnea with resistant HTN linked to increased risk of ischemic heart event, congestive heart failure.
Low aerobic capacity has greater effect than even high cholesterol, high blood pressure.
Commonly used meds linked to increased risk of hospitalization for dehydration, heat-related illness.
Notable improvement seen with carvedilol and nebivolol, but not betaxolol.
Future studies are needed to assess potential benefits of hypertension screening for daytime nappers.
Researchers found a 16% lower risk for strokes, heart attacks, and death combined among patients who took ACEIs or ARBs.
Only 40% of older patients transitioning to maintenance dialysis were on renin-angiotensin system blockade.
The FDA has developed 2- and 10-year goals to reduce sodium content in both processed and prepared foods.
Hypertension risk up for both short-term and long-term exposure.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)